Search for: "Ely v. Ely"
Results 101 - 120
of 1,843
Sorted by Relevance
|
Sort by Date
29 Aug 2016, 2:17 am
The issues in this case were remitted by the Court of Appeal in its June 2015 decision overturning the grant of DNIs regarding the same European Patent, which was based on reconstitution of Actavis’ pemetrexed product in saline (Actavis UK Limited v Eli Lilly & Company [2015] EWCA Civ 555). [read post]
30 May 2023, 10:15 am
The Duty to Respond to Public Comments In Perez v. [read post]
28 Sep 2007, 8:07 am
Eli Lilly & Co. v. [read post]
18 Oct 2011, 1:47 pm
Oral Argument in case# 10-3855; Susan Schaefer-LaRos v. [read post]
11 Dec 2006, 1:05 pm
Eli Lilly & Co. [read post]
8 May 2012, 11:35 am
In Susan Schaefer-LaRose v. [read post]
16 Nov 2006, 7:28 am
Ely, No. 06-5464 (6th Cir. [read post]
28 Jul 2010, 2:32 pm
Sun Pharmaceutical Industries, Ltd. v. [read post]
16 Aug 2015, 9:03 pm
Eli Lilly and Company et al. v. [read post]
1 Oct 2017, 9:43 pm
Eli Lilly & Co. (1996), and culminating in Ariad v. [read post]
14 Dec 2009, 9:59 pm
Eli Lilly & Co. last week, Chief Judge Michel asked Lilly's counsel whether Lilly had preserved the written description issue by timely objecting to District Court Judge Zobel's jury instruction (see "Ariad v. [read post]
2 Nov 2011, 12:57 pm
Still, you can’t blame the inventor for trying… The dispute in Human Genome Sciences v Eli Lilly is, by comparison, a whole other kettle of fish. [read post]
16 Jul 2022, 8:17 pm
Under West Virginia v. [read post]
25 Nov 2013, 6:00 am
See Prestonettes, Inc. v. [read post]
20 Oct 2022, 6:30 am
Ely had an important big idea—that judicial review (in a case like Brown v. [read post]
15 Jan 2015, 9:00 am
The case is pending in the Middle District of Pennslyvania, captioned as Ely et al. v. [read post]
17 Oct 2016, 6:34 am
Electrology Laboratory, Inc. v. [read post]
4 Apr 2007, 10:19 am
In Barricks, Lena v. [read post]
20 Dec 2009, 8:16 pm
Eli Lilly and Company v. [read post]
12 Jul 2017, 2:30 am
This appeal considered whether a new pemetrexed based cancer treatment produced by Actavis UK Ltd & others infringes Eli Lilly & Co’s patent and its foreign designations either indirectly under the Patents Act 1977, s 60(2) (matter for appeal) or directly under a proper interpretation of the Europe Patent Convention 2000, art 69 (matter for cross-appeal). [read post]
